Search results
Showing 1141 to 1155 of 2008 results for nice guidelines
Workplace health for employees with disabilities and long-term conditions
Discontinued Reference number: GID-PHG58
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer (HTG719)
Evidence-based recommendations on tumour profiling tests (EndoPredict, ICH4+C, MammaPrint, Oncotype DX and Prosigna) to guide adjuvant chemotherapy decisions in early breast cancer.
Intrapartum care for healthy women and babies - angle of episiotomy
Discontinued Reference number: GID-NG10394
Intrapartum care for healthy women and babies - rectal examination after delivery
Discontinued Reference number: GID-NG10395
Endometriosis: diagnosis and management - surgical management - pain management post-surgery
Discontinued Reference number: GID-NG10385
Evidence-based recommendations on durvalumab (Imfinzi) for treating limited-stage small-cell lung cancer that has not progressed after platinum-based chemoradiotherapy in adults.
Show all sections
NICE has developed a medtech innovation briefing (MIB) on ReStore Soft Exo-Suit for gait rehabilitation .
Discontinued Reference number: GID-NG10300
QuickChange Incontinence Wrap for urinary incontinence in men (MIB237)
NICE has developed a medtech innovation briefing (MIB) on QuickChange Incontinence Wrap for urinary incontinence in men .
Tildrakizumab for treating moderate to severe plaque psoriasis (TA575)
Evidence-based recommendations on tildrakizumab (Ilumetri) for treating moderate to severe plaque psoriasis in adults.
investigations before starting antipsychotic medicines recommended in the NICE guidelines on psychosis and schizophrenia in adults and...
Evidence-based recommendations on tucatinib (TUKYSA) for HER2-positive locally advanced or metastatic breast cancer in adults after 2 or more anti-HER2 treatment therapies.
Robot-assisted surgery for soft tissue procedures: early value assessment (HTG742)
Early value assessment (EVA) guidance on robot-assisted surgery for soft tissue procedures.
Smoking: smoking status of people with bipolar, schizophrenia and other psychoses (IND154)
This indicator covers the percentage of patients with schizophrenia, bipolar affective disorder or other psychoses whose notes record smoking status in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM124
with significant variation between different international and national guidelines. Current practice in the NHS is to give anti-D to all...